DEADLINE ALERT: Holzer & Holzer, LLC Reminds Investors of August 11, 2025 Lead Plaintiff Deadline in the Rocket Pharmaceuticals, Inc. (RCKT) Class Action – Investors With Significant Losses Encouraged to Contact the Firm

ATLANTA, July 28, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed Rocket Pharmaceuticals, Inc. (“Rocket Pharmaceuticals” or the “Company”) (NASDAQ: RCKT). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to adequately disclose that Rocket Pharmaceuticals knew Serious Adverse Events (SAEs), including death of participants enrolled in the study, were a risk. If you purchased shares of Rocket Pharmaceuticals between February 27, 202 ...